Blue Trust Inc. Reduces Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Blue Trust Inc. lessened its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 32.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,703 shares of the company’s stock after selling 1,319 shares during the period. Blue Trust Inc.’s holdings in Option Care Health were worth $63,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Entropy Technologies LP purchased a new position in Option Care Health during the 4th quarter valued at about $901,000. Jennison Associates LLC increased its stake in shares of Option Care Health by 4.5% during the 4th quarter. Jennison Associates LLC now owns 493,363 shares of the company’s stock worth $11,446,000 after purchasing an additional 21,089 shares in the last quarter. Highland Capital Management LLC acquired a new position in shares of Option Care Health during the 4th quarter worth approximately $238,000. Pacer Advisors Inc. lifted its stake in Option Care Health by 2.2% in the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock valued at $591,000 after buying an additional 537 shares in the last quarter. Finally, KBC Group NV lifted its stake in Option Care Health by 46.4% in the 4th quarter. KBC Group NV now owns 7,337 shares of the company’s stock valued at $170,000 after buying an additional 2,324 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on OPCH shares. Barrington Research boosted their price target on Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. JPMorgan Chase & Co. boosted their target price on shares of Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and upped their target price for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Truist Financial lowered their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. Finally, The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $32.25.

Option Care Health Price Performance

Option Care Health stock opened at $32.08 on Tuesday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market cap of $5.46 billion, a price-to-earnings ratio of 26.96, a PEG ratio of 2.30 and a beta of 1.35. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $34.17. The firm has a 50 day moving average price of $27.89 and a 200 day moving average price of $27.98.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.